Cargando…

Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project

BACKGROUND: Medication adherence to immunosuppressants in allogeneic stem cell transplantation (alloSCT) is essential to achieve favorable clinical outcomes (e.g. control of Graft-versus-Host Disease). Over 600 apps supporting medication adherence exist, yet they lack successful implementation and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribaut, Janette, Leppla, Lynn, Teynor, Alexandra, Valenta, Sabine, Dobbels, Fabienne, Zullig, Leah L., De Geest, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465386/
https://www.ncbi.nlm.nih.gov/pubmed/32878623
http://dx.doi.org/10.1186/s12913-020-05636-1
_version_ 1783577576247132160
author Ribaut, Janette
Leppla, Lynn
Teynor, Alexandra
Valenta, Sabine
Dobbels, Fabienne
Zullig, Leah L.
De Geest, Sabina
author_facet Ribaut, Janette
Leppla, Lynn
Teynor, Alexandra
Valenta, Sabine
Dobbels, Fabienne
Zullig, Leah L.
De Geest, Sabina
author_sort Ribaut, Janette
collection PubMed
description BACKGROUND: Medication adherence to immunosuppressants in allogeneic stem cell transplantation (alloSCT) is essential to achieve favorable clinical outcomes (e.g. control of Graft-versus-Host Disease). Over 600 apps supporting medication adherence exist, yet they lack successful implementation and sustainable use likely because of lack of end-user involvement and theoretical underpinnings in their development and insufficient attention to implementation methods to support their use in real-life settings. Medication adherence has three phases: initiation, implementation and persistence. We report the theory-driven development of an intervention module to support medication adherence (implementation and persistence phase) in alloSCT outpatients as a first step for future digitization and implementation in clinical setting within the SMILe project (Development, implementation and testing of an integrated care model in allogeneic SteM cell transplantatIon faciLitated by eHealth). METHODS: We applied Michie’s Behavior Change Wheel (BCW) and the Capability-Opportunity-Motivation and Behavior (COM-B) model using three suggested stages followed by one stage added by our team regarding preparation for digitization of the intervention: (I) Defining the problem in behavioral terms; (II) Identifying intervention options; (III) Identifying content and implementation options; (IV) SMILe Care Model Prototype Development. Scientific evidence, data from a contextual analysis and patients’/caregivers’ and clinical experts’ inputs were compiled to work through these steps. RESULTS: (I) Correct immunosuppressant taking and timing were defined as target behaviors. The intervention’s focus was determined within the COM-B dimensions Capability (lack of knowledge, lack of routine), Opportunity (lack of cues, interruptions in daily routine) and Motivation (lack of problem solving, trivialization). (II) Five intervention functions were chosen, i.e. education, training, modelling, persuasion and enablement. (III) Twenty-four behavior change techniques were selected, e.g., goal setting, action planning and problem solving. (IV) Finally, seventeen user stories were developed to guide the SMILeApp’s software development process. CONCLUSION: Our example on the theory-driven development of an intervention module in alloSCT delivered by eHealth and transplant team using a rigorous 3 + 1-stage approach based on BCW, COM-B and agile software development techniques, can be used as methodological guidance for other eHealth intervention developers. Our approach has the potential to enhance successful implementation and sustained use of eHealth solutions in real-life settings.
format Online
Article
Text
id pubmed-7465386
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74653862020-09-02 Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project Ribaut, Janette Leppla, Lynn Teynor, Alexandra Valenta, Sabine Dobbels, Fabienne Zullig, Leah L. De Geest, Sabina BMC Health Serv Res Research Article BACKGROUND: Medication adherence to immunosuppressants in allogeneic stem cell transplantation (alloSCT) is essential to achieve favorable clinical outcomes (e.g. control of Graft-versus-Host Disease). Over 600 apps supporting medication adherence exist, yet they lack successful implementation and sustainable use likely because of lack of end-user involvement and theoretical underpinnings in their development and insufficient attention to implementation methods to support their use in real-life settings. Medication adherence has three phases: initiation, implementation and persistence. We report the theory-driven development of an intervention module to support medication adherence (implementation and persistence phase) in alloSCT outpatients as a first step for future digitization and implementation in clinical setting within the SMILe project (Development, implementation and testing of an integrated care model in allogeneic SteM cell transplantatIon faciLitated by eHealth). METHODS: We applied Michie’s Behavior Change Wheel (BCW) and the Capability-Opportunity-Motivation and Behavior (COM-B) model using three suggested stages followed by one stage added by our team regarding preparation for digitization of the intervention: (I) Defining the problem in behavioral terms; (II) Identifying intervention options; (III) Identifying content and implementation options; (IV) SMILe Care Model Prototype Development. Scientific evidence, data from a contextual analysis and patients’/caregivers’ and clinical experts’ inputs were compiled to work through these steps. RESULTS: (I) Correct immunosuppressant taking and timing were defined as target behaviors. The intervention’s focus was determined within the COM-B dimensions Capability (lack of knowledge, lack of routine), Opportunity (lack of cues, interruptions in daily routine) and Motivation (lack of problem solving, trivialization). (II) Five intervention functions were chosen, i.e. education, training, modelling, persuasion and enablement. (III) Twenty-four behavior change techniques were selected, e.g., goal setting, action planning and problem solving. (IV) Finally, seventeen user stories were developed to guide the SMILeApp’s software development process. CONCLUSION: Our example on the theory-driven development of an intervention module in alloSCT delivered by eHealth and transplant team using a rigorous 3 + 1-stage approach based on BCW, COM-B and agile software development techniques, can be used as methodological guidance for other eHealth intervention developers. Our approach has the potential to enhance successful implementation and sustained use of eHealth solutions in real-life settings. BioMed Central 2020-09-02 /pmc/articles/PMC7465386/ /pubmed/32878623 http://dx.doi.org/10.1186/s12913-020-05636-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ribaut, Janette
Leppla, Lynn
Teynor, Alexandra
Valenta, Sabine
Dobbels, Fabienne
Zullig, Leah L.
De Geest, Sabina
Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
title Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
title_full Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
title_fullStr Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
title_full_unstemmed Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
title_short Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
title_sort theory-driven development of a medication adherence intervention delivered by ehealth and transplant team in allogeneic stem cell transplantation: the smile implementation science project
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465386/
https://www.ncbi.nlm.nih.gov/pubmed/32878623
http://dx.doi.org/10.1186/s12913-020-05636-1
work_keys_str_mv AT ribautjanette theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT lepplalynn theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT teynoralexandra theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT valentasabine theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT dobbelsfabienne theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT zulligleahl theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT degeestsabina theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject
AT theorydrivendevelopmentofamedicationadherenceinterventiondeliveredbyehealthandtransplantteaminallogeneicstemcelltransplantationthesmileimplementationscienceproject